Teladoc Health Appoints Michael Grasher As Chief Financial Officer; Stock Down

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.

Teladoc Health reported Q2 results with revenue of $606.93M and a net loss of $38.91M, and issued guidance expecting continued losses in Q3 and full-year 2026. The company lowered 2026 revenue guidance to $2.362B-$2.447B and net loss to $181M-$136M, citing pressure from BetterHelp as users shift to insurance-covered care.

Teladoc Health, owner of BetterHelp, said demand for insurance-covered therapy is outpacing its ability to credential therapists. In Q2, cash-pay therapy revenue fell faster than insurance revenue rose. BetterHelp revenue fell 12% YoY to $213M; insurance revenue was $22M. Shares dropped about 27% after results.

Teladoc Health (TDOC) shares fell about 20% in premarket after the company reported Q2 revenue of $606.9 million, down 4% year over year, and guided Q3 revenue to $569 million to $609 million versus a Street view of $629.3 million. Teladoc also forecast a Q3 loss of 30 cents to 20 cents per share.